Vasolan is a calcium channel blocking agent which suppresses tachyarrhythmia by blocking the influx of calcium ions into cells and slowing cardiac excitation.
Currently, Eisai seeks to establish other drug therapies suitable for use in the pediatric setting and remains committed to making further contributions to patients.